KBC Group NV - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.

Quarter-by-quarter ownership
KBC Group NV ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$1470.0%6,3550.0%0.00%0.0%
Q2 2023$147
-0.7%
6,3550.0%0.00%0.0%
Q1 2023$148
+11.3%
6,355
-9.0%
0.00%0.0%
Q4 2022$133
-99.9%
6,9830.0%0.00%0.0%
Q3 2022$133,000
+4.7%
6,9830.0%0.00%0.0%
Q2 2022$127,000
+296.9%
6,983
+505.6%
0.00%
Q4 2021$32,000
-13.5%
1,1530.0%0.00%
Q3 2021$37,000
-96.1%
1,153
-96.3%
0.00%
-100.0%
Q2 2021$960,000
+24.7%
31,404
+24.1%
0.00%0.0%
Q1 2021$770,000
-72.0%
25,3120.0%0.00%
+100.0%
Q4 2020$2,753,000
+620.7%
25,312
-13.6%
0.00%0.0%
Q3 2020$382,000
-10.3%
29,304
-21.9%
0.00%0.0%
Q2 2020$426,000
-31.5%
37,498
-13.8%
0.00%
-80.0%
Q1 2020$622,000
-29.0%
43,484
+35.2%
0.01%
-16.7%
Q4 2019$876,000
-4.9%
32,1640.0%0.01%
-14.3%
Q3 2019$921,000
+3.0%
32,1640.0%0.01%0.0%
Q2 2019$894,000
-16.3%
32,1640.0%0.01%
-22.2%
Q1 2019$1,068,000
+145.5%
32,164
+115.1%
0.01%
+80.0%
Q4 2018$435,000
-77.9%
14,955
-65.0%
0.01%
-66.7%
Q3 2018$1,965,000
+370.1%
42,719
+281.9%
0.02%
+275.0%
Q2 2018$418,000
-4.1%
11,187
-24.3%
0.00%0.0%
Q1 2018$436,000
+76.5%
14,770
+105.3%
0.00%
+100.0%
Q4 2017$247,000
+30.7%
7,193
+37.5%
0.00%0.0%
Q3 2017$189,000
+40.0%
5,2310.0%0.00%
+100.0%
Q2 2017$135,000
+35.0%
5,2310.0%0.00%0.0%
Q1 2017$100,000
-95.3%
5,231
-95.9%
0.00%
-95.2%
Q4 2016$2,109,000
-12.7%
126,534
+7.8%
0.02%
-27.6%
Q3 2016$2,417,000
-6.6%
117,431
+38.8%
0.03%
-21.6%
Q2 2016$2,589,000
-8.7%
84,595
+11.7%
0.04%
-21.3%
Q1 2016$2,835,000
-23.9%
75,754
-12.2%
0.05%
-31.9%
Q4 2015$3,725,000
+46.6%
86,312
+27.3%
0.07%
+35.3%
Q3 2015$2,541,000
-37.0%
67,788
-42.9%
0.05%
-1.9%
Q2 2015$4,033,000
-11.4%
118,662
-7.7%
0.05%
-10.3%
Q1 2015$4,550,000
+38.8%
128,544
+33.5%
0.06%
+48.7%
Q4 2014$3,279,000
+243.0%
96,266
+288.2%
0.04%
+18.2%
Q3 2014$956,000
-69.9%
24,796
-69.6%
0.03%
-8.3%
Q2 2014$3,173,000
+183.3%
81,534
+148.9%
0.04%
+100.0%
Q1 2014$1,120,000
+63.0%
32,7590.0%0.02%
+80.0%
Q4 2013$687,000
+1.5%
32,759
+13.9%
0.01%
-9.1%
Q3 2013$677,000
-15.9%
28,773
-4.0%
0.01%
-26.7%
Q2 2013$805,00029,9830.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders